Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=76a4e811-80db-49d7-82ec-71e1843b645e&Preview=1 Date 9/8/2011 Company Name Backupify Mailing Address 101 Rogers St. Cambridge, MA 02142 Company Description Backupify is not just about backup, it is about controlling your data yourself instead of having it stored in hundreds of services all around the web. Your online data is just as important as the data … Continue reading “Backupify Secures $5,000,000 Series B Funding”
Category: Boston
DynamicOps Secures New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9d0f2be4-19fb-4812-8cdf-17c1399c2001&Preview=1 Date 9/8/2011 Company Name DynamicOps Mailing Address One Wall Street Floor 2 Burlington, MA 01803 Company Description DynamicOps solutions transform the way cloud and virtual desktop infrastructure environments are managed so that organizations can quickly respond to and capitalize on market changes. Website http://www.dynamicops.com Transaction Type Venture Equity Transaction Amount Undisclosed … Continue reading “DynamicOps Secures New Financing”
Locu, Formerly Goodplates, Raises Seed Funding to Pursue Online Menu Platform
Locu, a Cambridge, MA-based Web startup, is closing its round of seed funding, with TechCrunch pegging the amount at $623,000. “We ended up getting a really diverse group of investors, both East Coast and West Coast,” CEO Rene Reinsberg tells me. That includes Boston angel investor and HubSpot founder Dharmesh Shah (also an investor in Xconomy), … Continue reading “Locu, Formerly Goodplates, Raises Seed Funding to Pursue Online Menu Platform”
Apperian CEO David Patrick to Moderate Xconomy “Consumers, the Cloud & Beyond” Chat with 3 Leading VCs
Venture capitalists are always interviewing entrepreneurs and CEOs—whether hearing pitches, sitting on boards, or looking for a chief executive to spark growth in a startup they have backed. It isn’t too often that the tables are turned. But they will be for Xconomy’s upcoming evening chat, Consumers, the Cloud & Beyond, featuring three leading venture … Continue reading “Apperian CEO David Patrick to Moderate Xconomy “Consumers, the Cloud & Beyond” Chat with 3 Leading VCs”
Ipierian Hires New CEO to Carry on With Stem Cells for Discovering Neurological Drugs
iPierian, the South San Francisco-based developer of stem cell technology co-founded by top scientists at Harvard University, said today it has hired a new CEO. Nancy Stagliano, the co-founder and former CEO of South San Francisco-based CytomX Therapeutics, has taken the top job at iPierian, while interim CEO Peter Van Vlasselaer has moved aside to … Continue reading “Ipierian Hires New CEO to Carry on With Stem Cells for Discovering Neurological Drugs”
Flexible Electronics Startup MC10 Adds $2.25M from Windham
Cambridge, MA-based MC10, a startup that designs stretchy, bendy electronics for various applications, said today it has completed its Series B financing with an additional $2.25 million from New York-based Windham Venture Partners. That brings the total round to $14.75 million, with North Bridge Venture Partners and Braemar Energy Ventures having previously invested. Windham is … Continue reading “Flexible Electronics Startup MC10 Adds $2.25M from Windham”
Tech Prom, Time Management, and the Future of Marketing: Q&A with Dave Balter
The best way to get to know Dave Balter is over a beer. The founder and CEO of Boston-based marketing firm BzzAgent (now part of U.K.-based Dunnhumby/Tesco) is known for speaking his mind, but over a beer it’s even better. I’m not sure what he was drinking when he replied to my e-mail yesterday as he … Continue reading “Tech Prom, Time Management, and the Future of Marketing: Q&A with Dave Balter”
(Mis)Understanding Drug Discovery: It’s Much Harder Than Rocket Science
Developing new medicines is an amazingly difficult undertaking. The research portion alone is daunting, and for those of us who have actually attempted it, humbling. A recent article reminded me just how little many people understand about the drug discovery process. The basic premise of “Pharma Needs an Innovation Intervention” was that pharma should change … Continue reading “(Mis)Understanding Drug Discovery: It’s Much Harder Than Rocket Science”
PTC Acquires 4CS, Goby Picked Up by TeleNav, Punchbowl Nabs Funding, & More Boston-Area Deals News
It may be a short week around here, but New England has already seen a crop of acquisitions in the Web, enterprise software, and cleantech spaces, along with some startup financing news. —Despite announcing deep cuts to its global R&D operation earlier this year, Pfizer signed a 10-year lease with MIT for more than 180,000 square … Continue reading “PTC Acquires 4CS, Goby Picked Up by TeleNav, Punchbowl Nabs Funding, & More Boston-Area Deals News”
MC10 Lands $2,250,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d4358505-1481-4ec1-aa22-5f44b82fd5ed&Preview=1 Date 9/7/2011 Company Name MC10 Mailing Address 36 Cameron Avenue Cambridge, MA 02140 Company Description MC10 startup developing stretchable silicon technology developed at the University of Illinois. Website http://www.mc10inc.com Transaction Type Venture Equity Transaction Amount $2,250,000 Transaction Round Series B Proceeds Purposes Windham provides experience and expertise that will boost mc10’s … Continue reading “MC10 Lands $2,250,000 Series B Round”
Locu Obtains $623,000 Seed Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0b30a62c-6313-45b0-bb81-352428b04af5&Preview=1 Date 9/7/2011 Company Name Locu Mailing Address Undisclosed Cambridge, MA 02139 Company Description Founded by MIT graduates and computer science researchers, Locu is creating the world’s largest semantically-annotated repository of real-time small-business data. We are excited to have the support and backing from a group of acclaimed angel investors and early-stage … Continue reading “Locu Obtains $623,000 Seed Funding Round”
Lead Syndax Drug Shows Survival Benefits in Breast Cancer Trial
Just two months after reporting positive data from a clinical trial of its lead drug candidate in lung cancer, Waltham, MA-based Syndax said today that the same drug performed well in a Phase 2 breast cancer trial. Results from the trial of the drug, called entinostat, will be presented at the American Society of Clinical … Continue reading “Lead Syndax Drug Shows Survival Benefits in Breast Cancer Trial”
Vlingo Lawsuit Charges Nuance With Unfair Competition and Commercial Bribery
A new front has been opened in the longstanding legal war between two Massachusetts speech technology powerhouses. On Thursday, Cambridge, MA-based Vlingo filed a lawsuit in U.S. District Court of Massachusetts charging its much bigger archrival with unfair competition, commercial bribery, breach of contract, and intentional interference with prospective business relationships. Among its chief allegations … Continue reading “Vlingo Lawsuit Charges Nuance With Unfair Competition and Commercial Bribery”
Arctaris Capital Partners Ventures Into Detroit
Why would Waltham, MA-based Arctaris Capital Partners, a venture capital firm seeking new approaches to investment in a post-recession market, choose to open an office in the city that, in the media at least, often serves as the poster child for the carnage wrought by the shrinking American economy? “We started in Detroit 18 months … Continue reading “Arctaris Capital Partners Ventures Into Detroit”
PTC Acquires 4CS for Warranty Management Software
PTC (NASDAQ: [[ticker:PMTC]]), the Needham, MA-based product development software maker, said today that it has acquired East Moline, IL-based 4CS, a maker of software for warranty and service management. The financial terms of the deal were not announced. PTC said the 4CS technology will work with its existing product lines that enable manufacturers to keep … Continue reading “PTC Acquires 4CS for Warranty Management Software”
Goby Bought by TeleNav; Watkins and Team to Keep Working on Location-Based Content
Another Boston-area software startup has been snapped up by a West Coast power. Sunnyvale, CA-based TeleNav (NASDAQ: [[ticker:TNAV]]), a location-based services firm, said today it has completed an acquisition of Boston-based Goby, a local and travel search startup that has recently focused on mobile apps. Terms of the deal weren’t given. (The news was buried … Continue reading “Goby Bought by TeleNav; Watkins and Team to Keep Working on Location-Based Content”
Harvest Power, Waste-to-Energy Startup with Big Investors, Buys Coastal Supply
It’s not often that soil and mulch makes the front page of Xconomy. But this is Harvest Power we’re talking about. The Waltham, MA-based cleantech company, which has operations in Seattle and Vancouver, BC, said today it has acquired Coastal Supply, a Delaware-based soil and mulch manufacturer. Terms of the deal weren’t disclosed. But Harvest … Continue reading “Harvest Power, Waste-to-Energy Startup with Big Investors, Buys Coastal Supply”
Extreme Reach, Profitable and Growing Fast, Looks to Go Big with New Financing
Extreme Reach is going through some extreme growth—and it’s about to get very interesting, very fast. The Needham, MA-based video-ad distribution startup is rumored to be raising a large investment round, one that could fuel its rise to become one of the Boston area’s top software startups. OK, advertising tech companies can be deadly boring … Continue reading “Extreme Reach, Profitable and Growing Fast, Looks to Go Big with New Financing”
Dramatic Changes in Hepatitis C Treatment Expected to Continue
Earlier this year the FDA approved telaprevir (Incivek) from Vertex Pharmaceuticals and boceprevir (Victrelis) from Merck for the treatment of hepatitis C. Both agents are protease inhibitors and represent the first approvals of direct acting antivirals for hepatitis C. Direct acting antivirals are a broad class of agents that act to block the growth of … Continue reading “Dramatic Changes in Hepatitis C Treatment Expected to Continue”
Fearless Fantasy Football, Uh, I Mean Biotech, Predictions for the Season Ahead
Football season is getting started this week, and I’m pumped. This is the time millions of people test their wits against friends (and strangers) in fantasy football. For fellow biotech nerds who aren’t familiar, this is a little bit like the stock market—you try to pick a diversified portfolio of pro football players who you … Continue reading “Fearless Fantasy Football, Uh, I Mean Biotech, Predictions for the Season Ahead”
GnuBio Obtains $5,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2a21a7e6-4f40-4b2c-8cdc-0696dddc82a1&Preview=1 Date 9/6/2011 Company Name GnuBio Mailing Address 64 Sidney St. Cambridge, MA 02139 Company Description GnuBIO is a genomics company developing next-generation sequencing technology for the molecular diagnostic and applied research markets. The GnuBIO system is based on emulsion and microfluidic technology developed at Harvard University. Website http://www.gnubio.com Transaction Type Venture … Continue reading “GnuBio Obtains $5,000,000 New Round”
BioRelix Secures $3,644,085 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c4dc9d2f-1888-4b9f-ab22-b88b1665efec&Preview=1 Date 9/6/2011 Company Name BioRelix Mailing Address 5 Science Park 401 Winchester Avenue New Haven, CT 06511-1989 Company Description BioRelix, Inc. is a market-driven company that discovers and develops antibiotics that target pathogens resistant to currently available drugs. BioRelix’ competitive advantage resides in the use of novel patented bacterial RNA targets … Continue reading “BioRelix Secures $3,644,085 New Funding”
General Compression Receives $5,500,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e92034c6-b4c7-44f1-a1d3-c73d383b8694&Preview=1 Date 9/6/2011 Company Name General Compression Mailing Address 275 Washington Street Newton, MA 02458 Company Description We are engineers, scientists, investors, and project developers, all committed to expanding clean power. General Compression’s systems are being developed to provide utility-scale storage and firming services for clean energy sources such as wind and … Continue reading “General Compression Receives $5,500,000 New Funding”
Understanding the Human Element of Startups: Inside NCIIA’s VentureLab
Written on the whiteboard on the first day of my entrepreneurship class at Tufts was a sobering statistic: 80 percent of startups die in their first four years. There exist a variety of factors that can kill a business. Luckily, Boston is full of programs and organizations designed to help entrepreneurs navigate through the startup … Continue reading “Understanding the Human Element of Startups: Inside NCIIA’s VentureLab”
Labor Day Friday Bad News Poll Results: Government Jobs Report the Worst Biz News of the Weekend
Well, it turned out that perhaps I was too cynical. On Friday morning, I posted the Labor Day Bad News Poll, pointing out that companies often buried bad news after markets closed on a Friday—and asking readers to predict what type of bad news they expected, if any, on the extra slow Friday before Labor … Continue reading “Labor Day Friday Bad News Poll Results: Government Jobs Report the Worst Biz News of the Weekend”
MyPad and the Coming Facebook Wars on the iPad
Why on earth isn’t there an official Facebook app for the iPad? The social networking giant has had an iPhone app ever since the launch of the iTunes App Store in 2008, and the company says that more than 250 million people access Facebook through mobile devices. Its engineers have tried to make the Facebook … Continue reading “MyPad and the Coming Facebook Wars on the iPad”
Pfizer Grows in Cambridge, Repligen Eyes Imaging Approval, GI Dynamics Gets Aussie IPO, & More Boston-Area Life Sciences News
New England biotech firms are roaring out of summer with news of fundraising, hires, regulatory moves, and acquisitions. —Cambridge, MA-based medical imaging startup Lantos Technologies announced a new round of funding and a new CEO. The firm pulled in $4.1 million in Series B money—led by return Lantos investor Excel Venture Management and with participation from … Continue reading “Pfizer Grows in Cambridge, Repligen Eyes Imaging Approval, GI Dynamics Gets Aussie IPO, & More Boston-Area Life Sciences News”
The Labor Day Friday Bad News Poll
Any savvy news hound knows that companies love to bury bad news by disclosing it after the close of markets on a Friday. The Friday before a long weekend like Labor Day is especially attractive. That got me wondering what bad news might be coming today. Is there another big CEO shuffle looming, a la … Continue reading “The Labor Day Friday Bad News Poll”
Punchbowl Software Lands $578,500 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6842cb29-f731-4512-8a70-11653aec94e8&Preview=1 Date 9/2/2011 Company Name Punchbowl Software Mailing Address 873 Concord Street Framingham, MA 01701 Company Description At Punchbowl Software, we believe that planning an event or party should be enjoyable and easy. Website http://www.mypunchbowl.com Transaction Type Venture Equity Transaction Amount $578,500 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. … Continue reading “Punchbowl Software Lands $578,500 New Financing Round”
TeleNav Acquires Goby Technologies for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dc411eeb-5384-43a2-9869-3d75ca5ffa10&Preview=1 Date 9/2/2011 Company Name Goby Technologies Mailing Address 201 South Street Boston, MA 02111 Company Description Goby is a search engine focused on exploring fun things to do with your free time, from taking a unique vacation to creating this weekend’s adventure. Website http://www.goby.com Transaction Type M&A Transaction Amount Undisclosed Transaction … Continue reading “TeleNav Acquires Goby Technologies for Undisclosed Sum”
Who’s Hiring, Who’s Starting, and Who’s Dead: A Pre-Labor Day Roundup of Tech Tidbits
Here in Boston, September 1st brings about quite a bit of change: students migrating back into town, moving trucks and furniture in the streets, and street cleaners around my office (all cutting down on parking options, sorry to say). We’ve weathered Tropical Storm Irene and a roller-coaster stock market, felt the mild rumblings of an … Continue reading “Who’s Hiring, Who’s Starting, and Who’s Dead: A Pre-Labor Day Roundup of Tech Tidbits”
Why Governments Don’t Get Startups–Or, Why There’s Only One Silicon Valley
Not understanding and agreeing what “entrepreneur” and “startup” mean can sink an entire country’s entrepreneurial ecosystem. I’m getting ready to go overseas to teach, and I’ve spent the last week reviewing several countries’ ambitious attempts to kick-start entrepreneurship. After poring through stacks of reports, white papers and position papers, I’ve come to a couple of … Continue reading “Why Governments Don’t Get Startups–Or, Why There’s Only One Silicon Valley”
Mascoma Gets New Financing, Plans 2011 Biorefinery Groundbreaking
Lebanon, NH-based biofuels company Mascoma Corporation has tapped a new $50 million convertible debt financing for $6.9 million, according to documents filed with the Securities and Exchange Commission on August 18. Thirty investors participated in the financing, including Hemant Taneja from General Catalyst Partners and Jim Matheson from Flagship Ventures. Mascoma announced in January that it … Continue reading “Mascoma Gets New Financing, Plans 2011 Biorefinery Groundbreaking”
Pfizer Beefs Up Cambridge Presence, Adding 400 Jobs in Kendall Square
Pfizer is gobbling up some prime biotech real estate in Cambridge, MA. The New York-based pharma company (NYSE: [[ticker:PFE]]) is adding space for 400 employees at the heart of the biotech R&D hub in Kendall Square. The world’s largest drug company—which greatly increased its Boston presence a couple years ago through the $68 billion acquisition … Continue reading “Pfizer Beefs Up Cambridge Presence, Adding 400 Jobs in Kendall Square”
Repligen Seeks Approval for Imaging Product While Pursuing Rare-Disease Drugs and Manufacturing Platform
Patients who arrive in the emergency room complaining of abdominal pain often have to undergo a type of endoscopy—an invasive and sometimes dangerous test— so doctors can determine if the problem is in the pancreas. Taking an MRI scan is a safer alternative, but the resulting images often aren’t sharp enough to make a proper … Continue reading “Repligen Seeks Approval for Imaging Product While Pursuing Rare-Disease Drugs and Manufacturing Platform”
Xconomist of the Week: Bob Langer’s Advice for Turning Foundation and Government Money into Startup Success
Yesterday, Selecta Biosciences—one of many companies founded by MIT professor and entrepreneur Bob Langer—announced that it had received a subcontract from the Science Applications International Corporation (SAIC) to develop a vaccine against malaria. The financial details weren’t released, but the initiative is part of a $76.5 million contract SAIC has with the National Institutes of … Continue reading “Xconomist of the Week: Bob Langer’s Advice for Turning Foundation and Government Money into Startup Success”
Wind Power Holdings Secures $10,132,428 Series C Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3e8fa6ab-cb53-468f-b494-23ef0384ba65&Preview=1 Date 9/1/2011 Company Name Wind Power Holdings Mailing Address 29 Pitman Road Barre, VT 05630 Company Description Northern Power (owned by Wind Power Holdings) has been delivering innovative wind energy solutions in a changing landscape for over 34 years. The company’s commitment to performance, reliability and cutting-edge technology has made it … Continue reading “Wind Power Holdings Secures $10,132,428 Series C Funding Round”
How to Build and Retain Value in a Slow Recovery
Next Stage Solutions is sponsoring this CEO workshop to help companies better understand how to build value over the long-term—not just in the current economy. The morning panel event will be held at New England Networking Solutions. Register here.
From Apps to Tools: Mobile Developer Raizlabs Gets Into the Platform Business with AppBlade
The world of mobile software applications has evolved so rapidly in the past couple of years, it will make your head spin. One guy whose head isn’t spinning, though, is mobile-app veteran Greg Raiz. In fact, he is probably doing the spinning for everyone else. Raiz is the founder and CEO of (aptly named) Raizlabs, … Continue reading “From Apps to Tools: Mobile Developer Raizlabs Gets Into the Platform Business with AppBlade”
George Scangos, the Boy From Working Class Boston, on His Road Back to Lead Biogen Idec
George Scangos spends much of his time these days in an office about 10 miles from the working class Greek neighborhood in Lynn, MA, where he grew up. You could say he’s come a long way in those 10 miles. The kid who didn’t speak English until he went to elementary school, and who didn’t … Continue reading “George Scangos, the Boy From Working Class Boston, on His Road Back to Lead Biogen Idec”
Xconomy’s “Consumers, the Cloud, and Beyond” Features 3 Top VCs on the Future of Venture and Entrepreneurship
A double dip recession may be looming. But you wouldn’t know it from the valuations of venture-backed companies like Facebook, Zynga, LinkedIn, Foursquare, Groupon, Gilt Groupe—as well as a host of other startups either based in the cloud and/or focused on the Internet and consumers. So is there some perfect, endless summer-type wave in these … Continue reading “Xconomy’s “Consumers, the Cloud, and Beyond” Features 3 Top VCs on the Future of Venture and Entrepreneurship”
Verizon Buys CloudSwitch, Adimab Inks Biogen and Novo Nordisk Deals, EMD Millpore Buys Amnis, & More Boston-Area Deals News
It looks like New England’s tech and life sciences firms are working to ink financing, collaboration, and acquisition deals before the holiday weekend hits. —Digital media and video-hosting firm Brightcove filed paperwork with the SEC indicating its hopes to raise $50 million in an initial public offering. Morgan Stanley and Stifel, Nicolaus & Company will … Continue reading “Verizon Buys CloudSwitch, Adimab Inks Biogen and Novo Nordisk Deals, EMD Millpore Buys Amnis, & More Boston-Area Deals News”
Placester Secures $826,212 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ca9306dd-9b67-43b8-bc44-c415c8974f56&Preview=1 Date 8/31/2011 Company Name Placester Mailing Address 1 Broadway Floor 14 Cambridge, MA 02142 Company Description We focus primarily on providing massive distribution, premium listing services, and deep analytics to help real estate companies advertise and generate business. We care deeply about improving the real estate industry through the use of … Continue reading “Placester Secures $826,212 New Funding Round”
CiDRA Receives $9,999,999 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=50277136-8ea6-46e5-b119-dbd45fa51e58&Preview=1 Date 8/31/2011 Company Name CiDRA Mailing Address 50 Barnes Park North Wallingford, CT 06492 Company Description Founded in 1996, CiDRA is the first company to combine industrial and optical skills to deliver real time process monitoring to multiple industries. Website http://www.cidra.com Transaction Type Venture Equity Transaction Amount $9,999,999 Transaction Round Undisclosed … Continue reading “CiDRA Receives $9,999,999 New Funding Round”
GI Dynamics Raises $85M USD in Aussie IPO
Lexington, MA-based GI Dynamics, a medical device developer focused on treating obesity and diabetes, has raised $85 million ($80 million in Australian dollars) in an initial public offering in Australia, according to an online report from The Australian. Earlier this summer the firm indicated that it hoped to go public in Australia, bringing in between $85 … Continue reading “GI Dynamics Raises $85M USD in Aussie IPO”
Amnis to Be Acquired by EMD Millipore of Merck KGaA
Some news from the world of life sciences equipment makers today. EMD Millipore, the Billerica, MA-based subsidiary of German pharmaceutical and chemical giant Merck KGaA, has agreed to acquire Seattle-based Amnis for an undisclosed sum. The deal is expected to close in the fourth quarter of this year. Millipore was bought by Merck KGaA for … Continue reading “Amnis to Be Acquired by EMD Millipore of Merck KGaA”
E La Carte Orders Up $4M More for Restaurant Tech
Boston-to-Silicon Valley transplant E la Carte has raised $4 million in new funding, according to a report in TechCrunch. The round was led by Lightbank. The startup previously raised more than $1 million in angel capital from investors including John Landry, Roy Rodenstein, Dave Balter, Dave McClure, Joshua Schachter, and Paul Buchheit. E la Carte, … Continue reading “E La Carte Orders Up $4M More for Restaurant Tech”
Black Coral’s Rob Day Talks Cleantech By Way of IT, Why Evergreen Solar’s Bankruptcy Isn’t the End, and Boston’s Energy Future
Two years ago, we took a close look at Boston-based Black Coral Capital, just as Rob Day was joining the newly formed, cleantech-focused private equity firm as partner. Since then, both the Day and Black Coral names have shown up as part of investments in some innovative cleantech plays in Boston—several that go beyond traditional … Continue reading “Black Coral’s Rob Day Talks Cleantech By Way of IT, Why Evergreen Solar’s Bankruptcy Isn’t the End, and Boston’s Energy Future”
The Startup Genome Compass
What makes startups succeed or fail? More than 90 percent of startups fail, due primarily to self-destruction rather than competition. For the less than 10 percent of startups that do succeed, most encounter several near death experiences along the way. Simply put, while we now have some good theory, we just are not very good … Continue reading “The Startup Genome Compass”
Adimab Inks Collaboration Deals with Biogen Idec, Novo Nordisk
Lebanon, NH-based Adimab, a provider of human antibody discovery technology, announced today that it has formed discovery collaborations with Weston, MA-based Biogen Idec (NASDAQ: [[ticker:BIIB]]) and Danish firm Novo Nordisk. Each pharmaceutical company will use the Adimab technology to identify human antibodies against two targets. The specific targets and the dollar terms of the deals … Continue reading “Adimab Inks Collaboration Deals with Biogen Idec, Novo Nordisk”